Clinical Trial Update: A Pharmacokinetic and Safety Study of Risperidone Long Acting Injectable in Schizophrenic Patients [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update covers pharmacokinetic and safety data for risperidone long-acting injectable in schizophrenia patients in Phase 1 and Phase 2; the s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Risperdal Consta (risperidone long-acting injectable)

Snippet

Sponsor: Janssen Pharmaceutical K.K. | Conditions: Schizophrenia | Phase 1, Phase 2 | Status: COMPLETED